Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

IM Cannabis Corp. (IMCC)

Compare
1.5800
+0.0100
+(0.64%)
At close: 4:00:00 PM EDT
1.5800
0.00
(0.00%)
After hours: 4:36:26 PM EDT
Loading Chart for IMCC
  • Previous Close 1.5700
  • Open 1.5900
  • Bid --
  • Ask --
  • Day's Range 1.5599 - 1.6451
  • 52 Week Range 1.5000 - 8.1000
  • Volume 4,036
  • Avg. Volume 12,006
  • Market Cap (intraday) 4.875M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -4.0400
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

imcannabis.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IMCC

View More

Performance Overview: IMCC

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

IMCC
31.87%
S&P/TSX Composite index (^GSPTSE)
2.79%

1-Year Return

IMCC
65.17%
S&P/TSX Composite index (^GSPTSE)
14.64%

3-Year Return

IMCC
98.80%
S&P/TSX Composite index (^GSPTSE)
15.28%

5-Year Return

IMCC
94.67%
S&P/TSX Composite index (^GSPTSE)
93.22%

Compare To: IMCC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMCC

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    4.74M

  • Enterprise Value

    14.32M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.10

  • Price/Book (mrq)

    1.16

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.59%

  • Return on Assets (ttm)

    -9.95%

  • Return on Equity (ttm)

    -139.75%

  • Revenue (ttm)

    54.03M

  • Net Income Avi to Common (ttm)

    -10.59M

  • Diluted EPS (ttm)

    -4.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    863k

  • Total Debt/Equity (mrq)

    572.54%

  • Levered Free Cash Flow (ttm)

    -7.51M

Research Analysis: IMCC

View More

Company Insights: IMCC

Research Reports: IMCC

View More

People Also Watch